Price
No data yet.
Social Signal Score
Revenue
$0.00Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- John S. Yu
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 4
- Beta
- 1.56
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- 5.11
Financials
Net Income
$-1.39MEBITDA
$-1.37MFree Cash Flow
$-1.01MEPS (diluted)
$-0.06Shares Outstanding (diluted)
21.42M+110.4%Operating Expenses
$1.42MCash & Debt
$2.63MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-5.45M | $-0.30 |
| 2024 | $0.00 | $-2.60M | $-0.23 |
| 2023 | $0.00 | $-1.81M | $-0.17 |
| 2022 | $0.00 | $-1.05M | $-0.10 |
| 2021 | $0.00 | $-2.15M | $-0.17 |
| 2020 | $0.00 | $-1.05M | $-0.09 |
Valuation
KAPAhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
60Social Signal Score
Mentions (1)
- Newsbusinesswire.com·5h ago·Negative
Kairos Pharma Announces 1-for-7 Reverse Stock Split LOS ANGELES--(BUSINESS WIRE)---- $KAPA--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on overcoming cancer drug resistance, today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-7 (the “Reverse Stock Split”). The Reverse Stock Split is expected to become effective on September 1, 2026 at 12:01 a.m. ET (the “Effective Time”), with s…
View source ↗
Earnings
Fri, Nov 13(in 3 months)
Consensus estimate $-0.09 per share
Typical surprise -33.3% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 12$-0.06 vs $-0.09beat
- Wed, May 13$-0.08 vs $-0.07miss
- Tue, Mar 31$-0.07 vs $-0.02miss
- Fri, Nov 14$-0.07 vs $-0.10beat
- Tue, Aug 12$-0.08 vs $-0.06miss
- Tue, Apr 15$-0.08 vs $-0.05miss
Estimates and results for KAPA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by KAPA officers and directors.
- Bought
- $10k
- Sold
- —
3 trades
0 trades
- Murali Ramachandranbought
- Samuelson Dougbought
- Yu John Sbought
20 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.